Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds

Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Yunting Luo, Shen Shu Sung, Ann Marie Szymanski, M. L.Richard Yip, Wayne C. Guida, Saïd M. Sebti, Jie Wu, Nicholas J. Lawrence

    Research output: Contribution to journalArticlepeer-review

    92 Scopus citations

    Abstract

    Screening of the NCI diversity set of compounds has led to the identification of 5 (NSC-117199), which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM. A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities. Several compounds were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity. A model for the binding of the active compounds is proposed.

    Original languageEnglish (US)
    Pages (from-to)4948-4956
    Number of pages9
    JournalJournal of Medicinal Chemistry
    Volume51
    Issue number16
    DOIs
    StatePublished - Aug 28 2008

    All Science Journal Classification (ASJC) codes

    • Molecular Medicine
    • Drug Discovery

    Fingerprint

    Dive into the research topics of 'Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds'. Together they form a unique fingerprint.

    Cite this